Details for Patent: 7,500,444

Which drugs does patent 7,500,444 protect, and when does it expire?

Patent 7,500,444 protects ADVAIR HFA and FLOVENT HFA and is included in two NDAs.

Protection for ADVAIR HFA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-nine patent family members in seventeen countries.

Summary for Patent: 7,500,444

Title:	Actuation indicator for a dispensing device
Abstract:	An actuation indicator that includes a drum sub-assembly, which includes a rotatable actuation indicator wheel, a rocking, ratchet pawl for rotating the indicator wheel in a set direction and a rocking mechanism for the pawl driven by a slipping clutch arrangement, is described. The slipping clutch arrangement includes a slipping clutch spring engaged at one end to a pinion of a rack and pinion assembly and at a second end to the ratchet pawl.
Inventor(s):	Bonney; Stanley George (Ware, GB), Brand; Peter John (Ware, GB), Godfrey; James William (Ware, GB), Rand; Paul Kenneth (Ware, GB)
Assignee:	Glaxo Group Limited (Greenford, Middlesex, GB)
Application Number:	10/518,421
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,500,444
Patent Claim Types: see list of patent claims	Use;

Recent additions to Drugs Protected by US Patent 7,500,444

These patents are from the daily update and have not yet been integrated into the regular database

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Type	RLD	Patent No.	Product	Substance	Delist Req.	Patent Expiration	Usecode	Patented / Exclusive Use
Glaxo Grp Ltd	ADVAIR HFA	fluticasone propionate; salmeterol xinafoate	AEROSOL, METERED	021254	Jun 8, 2006	RX	Yes		Y

Drugs Protected by US Patent 7,500,444

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Glaxo Grp Ltd	ADVAIR HFA	fluticasone propionate; salmeterol xinafoate	AEROSOL, METERED;INHALATION	021254-001	Jun 8, 2006		RX	Yes	Yes					Y
Glaxo Grp Ltd	ADVAIR HFA	fluticasone propionate; salmeterol xinafoate	AEROSOL, METERED;INHALATION	021254-003	Jun 8, 2006		RX	Yes	Yes					Y
Glaxo Grp Ltd	FLOVENT HFA	fluticasone propionate	AEROSOL, METERED;INHALATION	021433-002	May 14, 2004		RX	Yes	Yes					Y

Foreign Priority and PCT Information for Patent: 7,500,444

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0214360.0	Jun 21, 2002
United Kingdom	0311191.1	May 15, 2003

PCT Information
PCT Filed	June 19, 2003	PCT Application Number:	PCT/EP03/06466
PCT Publication Date:	December 31, 2003	PCT Publication Number:	WO04/001664

International Family Members for US Patent 7,500,444

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	424010
Australia	2003278236
Brazil	0311557